Baby Safety / Compounds / MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline)

Is MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline) safe for babies and kids?

Elevated risk for kids

Infants face elevated exposure to MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline) through formula, baby food, and breast milk contamination. Immature hepatic metabolism and higher intake-to-body-weight ratio amplify dose.

What is meiqx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline)?

The IUPAC name is 3,4-dimethylimidazo[4,5-f]quinolin-2-amine.

Also known as: 3,4-dimethylimidazo[4,5-f]quinolin-2-amine, MeIQ, Me-IQ, 3,4-dimethyl-3H-imidazo[4,5-f]quinolin-2-amine.

IUPAC name: 3,4-dimethylimidazo[4,5-f]quinolin-2-amine
CAS number: 77094-11-2
Molecular formula: C12H12N4
Molecular weight: 212.25 g/mol
SMILES: CC1=CC2=C(C=CC=N2)C3=C1N(C(=N3)N)C
PubChem CID: 62274

Risk for babies

Elevated risk

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters metabolism and increases susceptibility to MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline). Dietary additives consumed during pregnancy cross the placenta; safety margins for adults may not protect the developing fetus.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

6 regulatory and scientific bodies have classified MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline). The classifications differ — that's the data.

Agency	Year	Classification	Notes
IARC	1993	Group 2B (possibly carcinogenic to humans)	IARC Monograph 56 (1993). Sufficient evidence in experimental animals (liver, colon, Zymbal gland tumors in rats); limited evidence in humans. Second most abundant heterocyclic amine (HCA) in cooked muscle meats after PhIP. Forms from creatinine + amino acids at high temperatures (Maillard reaction). Requires metabolic activation via CYP1A2 and NAT2 to form reactive N-acetoxy ester that binds deoxyguanosine.
EPA CTX / NTP RoC	—	Reasonably Anticipated to be a Human Carcinogen
EPA CTX / IARC	—	Group 2B - Possibly carcinogenic to humans
EPA CTX / CalEPA	—	Known human carcinogen
EPA CTX / Genetox	—	Genotoxicity: positive (Ames: positive, 6 positive / 0 negative reports)
EPA CTX / Genetox	—	Genotoxicity: positive (Ames: positive, 6 positive / 0 negative reports)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter meiqx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline)

Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
Occupational Environments — Factories, Warehouses, Transportation vehicles
Food — processed food, beverages, candy, baked goods

Safer alternatives

Lower-risk approaches that achieve a similar outcome to MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline):

Natural preservatives; Clean-label ingredients; Minimally processed food
Trade-offs: Consumer label appeal ('clean label'); variable efficacy depending on food matrix and target pathogen; may alter flavor/color; regulatory status varies by jurisdiction; often more expensive per unit of preservation effect.

Relative cost: 2-5× conventional

Frequently asked questions

Is meiqx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline) safe for kids?

What products contain meiqx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline)?

MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments); processed food (Food).

What should I do if my child is exposed to meiqx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about meiqx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline)?

MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline) has been classified by 6 agencies including IARC, EPA CTX / NTP RoC, EPA CTX / IARC, EPA CTX / CalEPA, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline) in the baby app

Look up products containing meiqx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (3)

IARC Monographs Volume 56: MeIQx and Other Heterocyclic Amines (1993) — regulatory
NCI: Heterocyclic Amines and Polycyclic Aromatic Hydrocarbons in Cooked Meats — Consumer Guidance (2022) — report
WHO Safety Evaluation of Certain Food Additives and Contaminants: Heterocyclic Amines (1994) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →